• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ALPN

ALPN

Alpine Immune Sciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD64.97

+0.01 (+0.02%)

Company Profile

CEO

Mitchell H. Gold

IPO Date

2015-06-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$64.98

Prev. Close

$64.96

Day Low

$64.97

Day High

$65.00

52W Low

$8.33

52W High

$65.00

Market Cap

$4.46B

Volume

4.29M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

34.1%

Avg Negative

2.1%

Avg Neutral

63.8%

News Feed

Celldex: Powerful Medicines To Yield Further Upsides

Seeking Alpha·7/8/2021·↑ positive

Alpine Immune Sciences Announces ALPN-202 Clinical Data Presented at the 2021 ASCO Virtual Annual Meeting

Business Wire·6/4/2021·↑ positive

Alpine Immune Sciences' Autoimmune Disease Candidate ALPN-303 Shows Promise in Preclinical Studies

Benzinga·6/3/2021
·↑ positive

Alpine Immune Sciences Presents ALPN-303 Data During the 2021 EULAR Virtual Meeting

Business Wire·6/2/2021·↑ positive

Alpine Immune Sciences: Better Days Ahead

Seeking Alpha·5/30/2021·↑ positive

3 Biotech Stocks That Jumped Higher Last Week

The Motley Fool·5/23/2021·↑ positive

Alpine Immune Sciences, Inc. (ALPN) Moves 9.5% Higher: Will This Strength Last?

Zacks Investment Research·5/20/2021·↑ positive

Alpine Immune Sciences To Host Investor Event at 2021 ASCO Virtual Annual Meeting

Business Wire·5/19/2021·↑ positive

Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research·5/13/2021·↑ positive

Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline

Zacks Investment Research·5/6/2021·↑ positive